ESR1 and breast cancer: When considering diagnostic performance, [18F]FES PET or PET/CT showed high pooled sensitivity and specificity in evaluating the expression of ER in BC lesions: pooled sensitivity and specificity ranged from 81% to 94% and from 78% to 95%, respectively [12,18,19,20,22,23,24] (Table 2).